Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 56

1.

Bendamustine, lenalidomide and dexamethasone (BRd) has high activity as 2nd -line therapy for relapsed and refractory multiple myeloma - a phase II trial.

Mey UJ, Brugger W, Schwarb H, Pederiva S, Schwarzer A, Dechow T, Jehner P, Rauh J, Taverna CJ, Schmid M, Schmidt-Hieber M, Doerfel S, Fischer N, Ruefer A, Ziske C, Knauf W, Cathomas R, von Moos R, Hitz F, Sauter R, Hiendlmeyer E, Cantoni N, Bargetzi M, Driessen C.

Br J Haematol. 2017 Mar;176(5):770-782. doi: 10.1111/bjh.14481. Epub 2016 Dec 16.

PMID:
27983764
2.

Unmentioned Side Effects.

Ziske C.

Dtsch Arztebl Int. 2015 Oct 23;112(43):738-9. doi: 10.3238/arztebl.2015.0738b. No abstract available.

3.

Primary small cell carcinoma of the esophagus: patient data metaanalysis and review of the literature.

Al Mansoor S, Ziske C, Schmidt-Wolf IG.

Ger Med Sci. 2013 Aug 23;11:Doc12. doi: 10.3205/000180. eCollection 2013. Review.

4.

What constitutes best supportive care in the treatment of advanced non-small cell lung cancer patients?--Results from the lung cancer economics and outcomes research (LUCEOR) study.

Lester JF, Agulnik J, Akerborg O, Chouaid C, De Geer A, Finnern HW, Herder GJ, Lungershausen J, Mitchell PL, Vansteenkiste J, Ziske C, Goker E.

Lung Cancer. 2013 Oct;82(1):128-35. doi: 10.1016/j.lungcan.2013.06.023. Epub 2013 Jul 31.

PMID:
23910909
5.

Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial.

Lordick F, Kang YK, Chung HC, Salman P, Oh SC, Bodoky G, Kurteva G, Volovat C, Moiseyenko VM, Gorbunova V, Park JO, Sawaki A, Celik I, Götte H, Melezínková H, Moehler M; Arbeitsgemeinschaft Internistische Onkologie and EXPAND Investigators.

Lancet Oncol. 2013 May;14(6):490-9. doi: 10.1016/S1470-2045(13)70102-5. Epub 2013 Apr 15.

PMID:
23594786
6.

[Immunoglobulins in PID, SID and neurological autoimmune disease].

Borte M, Baumann U, Pittrow D, Hensel M, Fasshauer M, Huscher D, Reiser M, Stangel M, Gold R, Kirch W; Liste der aktuell beitragenden Zentren, sortiert nach Postleitzahlen (mindestens ein Patient zum 1.3.2012).

Dtsch Med Wochenschr. 2012 Mar;137(13):675-80. doi: 10.1055/s-0032-1304844. Epub 2012 Mar 20. Review. German.

PMID:
22434180
7.

A prospective multicenter phase II study of oral and i.v. vinorelbine plus trastuzumab as first-line therapy in HER2-overexpressing metastatic breast cancer.

Heinemann V, Di Gioia D, Vehling-Kaiser U, Harich HD, Heinrich B, Welt A, Ziske C, Deutsch G, Pihusch R, Kölbl H, Hegewisch-Becker S, Michl M, Stemmler HJ.

Ann Oncol. 2011 Mar;22(3):603-8. doi: 10.1093/annonc/mdq409. Epub 2010 Aug 19.

PMID:
20724574
8.

Enhanced inhibition of tumor growth with depletion of CD25 regulatory cells and intratumoral immunization with tumor RNA-pulsed dendritic cells in a C57BL/6 pancreatic tumor model.

Linke A, Brossart P, Schmidt-Wolf IG, Gonzalez-Carmona MA, Ziske C, Messmer D, Schmitz V, Sauerbruch T.

Pancreas. 2009 Jul;38(5):602-4. doi: 10.1097/MPA.0b013e3181a11bde. No abstract available.

PMID:
19550282
9.

Increase of in vivo antitumoral activity by CD40L (CD154) gene transfer into pancreatic tumor cell-dendritic cell hybrids.

Ziske C, Etzrodt PE, Eliu AS, Gorschlüter M, Strehl J, Flieger D, Messmer D, Schmitz V, Gonzalez-Carmona MA, Sievers E, Brossart P, Sauerbruch T, Schmidt-Wolf IG.

Pancreas. 2009 Oct;38(7):758-65. doi: 10.1097/MPA.0b013e3181ae5e1a.

PMID:
19546834
10.

Pancreas carcinoma antigen fused to invariant chain elicits T-cell response and tumor growth inhibition.

Nagaraj S, Neumann J, Winzen B, Frank S, Ziske C, Sievers E, Koch N, Schmidt-Wolf IG.

Pancreas. 2008 Oct;37(3):321-7. doi: 10.1097/MPA.0b013e318166722e7.

PMID:
18815556
11.

Prevention of lethal tumor growth and generation of long-lasting immunity in vivo using CD137L and interleukin-12 gene transfer.

Kim Y, Strehl JW, Gorschlüter M, Ziske C, Schmidt-Wolf IG.

In Vivo. 2008 May-Jun;22(3):337-43.

12.

Real-time high-resolution compound imaging allows percutaneous initiation and surveillance in an orthotopic murine pancreatic cancer model.

Ziske C, Tiemann K, Schmidt T, Nagaraj S, Märten A, Schmitz V, Clarenbach R, Sauerbruch T, Schmidt-Wolf IG.

Pancreas. 2008 Mar;36(2):146-52. doi: 10.1097/MPA.0b013e3181586cd9.

PMID:
18376305
13.

Minimal size MIDGE vectors improve transgene expression in vivo.

Schakowski F, Gorschlüter M, Buttgereit P, Märten A, Lilienfeld-Toal MV, Junghans C, Schroff M, König-Merediz SA, Ziske C, Strehl J, Sauerbruch T, Wittig B, Schmidt-Wolf IG.

In Vivo. 2007 Jan-Feb;21(1):17-23.

14.

Pegfilgrastim as hematopoietic support for dose-dense chemoimmunotherapy with R-CHOP-14 as first-line therapy in elderly patients with diffuse large B cell lymphoma.

Mey UJ, Maier A, Schmidt-Wolf IG, Ziske C, Forstbauer H, Banat GA, Reber M, Strehl JW, Gorschlueter M.

Support Care Cancer. 2007 Jul;15(7):877-84.

PMID:
17235504
15.

Dendritic cells pulsed with alpha-galactosylceramide induce anti-tumor immunity against pancreatic cancer in vivo.

Nagaraj S, Ziske C, Strehl J, Messmer D, Sauerbruch T, Schmidt-Wolf IG.

Int Immunol. 2006 Aug;18(8):1279-83. Epub 2006 Jun 13.

PMID:
16772371
16.

Invasive fungal infections in neutropenic enterocolitis: a systematic analysis of pathogens, incidence, treatment and mortality in adult patients.

Gorschlüter M, Mey U, Strehl J, Schmitz V, Rabe C, Pauls K, Ziske C, Schmidt-Wolf IG, Glasmacher A.

BMC Infect Dis. 2006 Feb 26;6:35.

17.

Total ascitic fluid leukocyte count for reliable exclusion of spontaneous bacterial peritonitis in patients with ascites.

Link BC, Ziske CG, Schepke M, Schmidt-Wolf IG, Sauerbruch T.

Eur J Gastroenterol Hepatol. 2006 Feb;18(2):181-6.

PMID:
16394800
18.

Comparison of rapidly cycled tandem high-dose chemotherapy plus peripheral-blood stem-cell support versus dose-dense conventional chemotherapy for adjuvant treatment of high-risk breast cancer: results of a multicentre phase III trial.

Nitz UA, Mohrmann S, Fischer J, Lindemann W, Berdel WE, Jackisch C, Werner C, Ziske C, Kirchner H, Metzner B, Souchon R, Ruffert U, Schütt G, Pollmanns A, Schmoll HJ, Middecke C, Baltzer J, Schrader I, Wiebringhaus H, Ko Y, Rösel S, Schwenzer T, Wernet P, Hinke A, Bender HG, Frick M; West German Study Group.

Lancet. 2005 Dec 3;366(9501):1935-44. Erratum in: Lancet. 2006 Mar 4;367(9512):730.

PMID:
16325695
19.

Neutropenic enterocolitis in adults: systematic analysis of evidence quality.

Gorschlüter M, Mey U, Strehl J, Ziske C, Schepke M, Schmidt-Wolf IG, Sauerbruch T, Glasmacher A.

Eur J Haematol. 2005 Jul;75(1):1-13. Review.

PMID:
15946304
20.

Transfection of human monocyte-derived dendritic cells with CpG oligonucleotides.

Erhardt M, Gorschlüter M, Sager J, Ziske C, Strehl J, Lilienfeld-Toal MV, Schmidt-Wolf IG.

Immunol Cell Biol. 2005 Jun;83(3):278-85.

PMID:
15877606

Supplemental Content

Loading ...
Support Center